Amanote Research
Register
Sign In
THU0435 Pharmacodynamics, Pharmacokinetics, and Safety of Verinurad (RDEA3170) in Combination With Febuxostat Versus Febuxostat Alone and Verinurad Alone in Japanese Adults With Gout or Asymptomatic Hyperuricemia: A Phase 2A, Open-Label Study
doi 10.1136/annrheumdis-2017-eular.5391
Full Text
Open PDF
Abstract
Available in
full text
Date
June 1, 2017
Authors
M Shiramoto
S Liu
Z Shen
J Hall
Publisher
BMJ Publishing Group Ltd and European League Against Rheumatism
Related search
Pharmacodynamic and Pharmacokinetic Effects and Safety of Verinurad in Combination With Allopurinol in Adults With Gout: A Phase IIa, Open-Label Study
RMD Open
Rheumatology
Allergy
Immunology
THU0432 Pharmacokinetics, Pharmacodynamics, and Tolerability of Concomitant Multiple Dose Administration of Verinurad (RDEA3170) and Allopurinol in Adult Male Subjects With Gout
Pharmacokinetics and Pharmacodynamics of Febuxostat Under Fasting Conditions in Healthy Individuals
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
Pharmacokinetics, Pharmacodynamics, and Tolerability of Verinurad, a Selective Uric Acid Reabsorption Inhibitor, in Healthy Japanese and Non-Asian Male Subjects
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Febuxostat: The Evidence for Its Use in the Treatment of Hyperuricemia and Gout
Core Evidence
Medicine
Reviews
References
Pharmacology
The Urate-Lowering Efficacy and Safety of Febuxostat in the Treatment of the Hyperuricemia of Gout: The CONFIRMS Trial
Arthritis Research and Therapy
Rheumatology
Allergy
Immunology
The Future of Febuxostat After the Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Morbidities (CARES) Trial: Who CARES?
Expert Opinion on Pharmacotherapy
Medicine
Pharmacology
Treatment of Gout With Allopurinol and Sulphinpyrazone in Combination and With Allopurinol Alone
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Effect of Febuxostat on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension: A Phase 2 Randomized Placebo‐Controlled Study
Journal of the American Heart Association
Cardiovascular Medicine
Cardiology
